Elevated cerebrospinal fluid tumour necrosis factor is associated with acute and long-term neurocognitive impairment in cerebral malaria

Parasite Immunology

Volumn 39, Issue 7, 2017, Pages

  Shabani, E ^a,b   Ouma, B J ^c   Idro, R ^c   Bangirana, P ^c   Opoka, R O ^c   Park, G S ^a   Conroy, A L ^b   John, C C ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

Author keywords

neurocognitive impairment; paediatric cerebral malaria; tumour necrosis factor alpha

Indexed keywords

ARTEMISININ; QUININE; TUMOR NECROSIS FACTOR;

ARTICLE; BIOMASS; CENTRAL NERVOUS SYSTEM; CEREBRAL MALARIA; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CHILD; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; COMA; DISEASE MARKER; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MORTALITY; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; NORTH AMERICAN; NUTRITION; OPHTHALMOSCOPY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN CEREBROSPINAL FLUID LEVEL; RETINOPATHY; UGANDA; BLOOD; COMPLICATION; DISORDERS OF HIGHER CEREBRAL FUNCTION; IMMUNOLOGY; INFANT; PARASITOLOGY; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HUMANS; INFANT; MALARIA, CEREBRAL; MALE; NEUROCOGNITIVE DISORDERS; PLASMODIUM FALCIPARUM; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; UGANDA;

EID: 85019677538     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/pim.12438     Document Type: Article

References (50)

1. Bangirana P, Opoka RO, Boivin MJ, et al. Severe malarial anemia is associated with long-term neurocognitive impairment. Clin Infect Dis. 2014;59:336-344.
2. Seydel KB, Kampondeni SD, Valim C, et al. Brain swelling and death in children with cerebral malaria. N Engl J Med. 2015;372:1126-1137.
3. Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am J Trop Med Hyg. 2001;64(1–2 Suppl):57-67.
4. Boivin MJ, Bangirana P, Byarugaba J, et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics. 2007;119:e360-e366.
5. John CC, Bangirana P, Byarugaba J, et al. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics. 2008;122:e92-e99.
6. Berendt AR, Simmons DL, Tansey J, Newbold CI, Marsh K. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature. 1989;341:57-59.
7. Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med. 1996;334:1717-1725.
8. Clark IA, Hunt NH, Butcher GA, Cowden WB. Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole. J Immunol. 1987;139:3493-3496.
9. Jacobs P, Radzioch D, Stevenson MM. A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect Immun. 1996;64:535-541.
10. Stevenson MM, Ghadirian E. Human recombinant tumor necrosis factor alpha protects susceptible A/J mice against lethal Plasmodium chabaudi AS infection. Infect Immun. 1989;57:3936-3939.
11. Taverne J, Tavernier J, Fiers W, Playfair JH. Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol. 1987;67:1-4.
12. Grau GE, Fajardo LF, Piguet PF, et al. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science. 1987;237:1210-1212.
13. Rudin W, Eugster HP, Bordmann G, et al. Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am J Pathol. 1997;150:257-266.
14. Shaffer N, Grau GE, Hedberg K, et al. Tumor necrosis factor and severe malaria. J Infect Dis. 1991;163:96-101.
15. Kern P, Hemmer CJ, Van Damme J, Gruss HJ, Dietrich M. Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med. 1989;87:139-143.
16. Kwiatkowski D, Hill AV, Sambou I, et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990;336:1201-1204.
17. Tchinda VH, Tadem AD, Tako EA, et al. Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha. Acta Trop. 2007;102:20-28.
18. Walther M, Jeffries D, Finney OC, et al. Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog. 2009;5:e1000364.
19. Grau GE, Taylor TE, Molyneux ME, et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 1989;320:1586-1591.
20. Esamai F, Ernerudh J, Janols H, et al. Cerebral malaria in children: serum and cerebrospinal fluid TNF-alpha and TGF-beta levels and their relationship to clinical outcome. J Trop Pediatr. 2003;49:216-223.
21. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994;371:508-510.
22. Knight JC, Udalova I, Hill AV, et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet. 1999;22:145-150.
23. van Hensbroek MB, Palmer A, Onyiorah E, et al. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis. 1996;174:1091-1097.
24. Medana IM, Hunt NH, Chaudhri G. Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am J Pathol. 1997;150:1473-1486.
25. John CC, Panoskaltsis-Mortari A, Opoka RO, et al. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg. 2008;78:198-205.
26. Udomsangpetch R, Chivapat S, Viriyavejakul P, et al. Involvement of cytokines in the histopathology of cerebral malaria. Am J Trop Med Hyg. 1997;57:501-506.
27. Brown H, Turner G, Rogerson S, et al. Cytokine expression in the brain in human cerebral malaria. J Infect Dis. 1999;180:1742-1746.
28. Armah H, Dodoo AK, Wiredu EK, et al. High-level cerebellar expression of cytokines and adhesion molecules in fatal, paediatric, cerebral malaria. Ann Trop Med Parasitol. 2005;99:629-647.
29. Villaverde C, Namazzi R, Shabani E, Opoka RO, John CC. Clinical comparison of retinopathy-positive and retinopathy-negative cerebral malaria. Am J Trop Med Hyg. 2017. doi: 10.4269/ajtmh.16-0315. [Epub ahead of print].
30. Mullen EM. Mullen Scales of Early Learning manual. AGS ed. Circle Pines, MN: American Guidance Service; 1995. ix, 85 p.
31. Goldman DZ, Shapiro EG, Nelson CA. Measurement of vigilance in 2-year-old children. Dev Neuropsychol. 2004;25:227-250.
32. Kaufman AS, Kaufman NL. KABC-II: Kaufman Assessment Battery for Children, 2nd edn. Circle Pines, MN: AGS Pub; 2004.
33. Greenberg LM, Waldman ID. Developmental normative data on the test of variables of attention (T.O.V.A.). J Child Psychol Psychiatry. 1993;34:1019-1030.
34. Dondorp AM, Desakorn V, Pongtavornpinyo W, et al. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med. 2005;2:e204.
35. Taylor TE, Fu WJ, Carr RA, et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med. 2004;10:143-145.
36. Kleiner G, Marcuzzi A, Zanin V, Monasta L, Zauli G. Cytokine levels in the serum of healthy subjects. Mediators Inflamm. 2013;2013:434010.
37. Sack U, Burkhardt U, Borte M, et al. Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diagn Lab Immunol. 1998;5:28-32.
38. Liu T, Clark RK, McDonnell PC, et al. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke. 1994;25:1481-1488.
39. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc Natl Acad Sci USA. 1995;92:11294-11298.
40. Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481-487.
41. Prasad R, Kapoor R, Srivastava R, Mishra OP, Singh TB. Cerebrospinal fluid TNF-alpha, IL-6, and IL-8 in children with bacterial meningitis. Pediatr Neurol. 2014;50:60-65.
42. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med. 1989;170:607-612.
43. Boka G, Anglade P, Wallach D, et al. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett. 1994;172:151-154.
44. Brown H, Hien TT, Day N, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999;25:331-340.
45. Frei K, Siepl C, Groscurth P, et al. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol. 1987;17:1271-1278.
46. Chung IY, Benveniste EN. Tumor necrosis factor-alpha production by astrocytes. Induction by lipopolysaccharide, IFN-gamma, and IL-1 beta. J Immunol. 1990;144:2999-3007.
47. Hochman SE, Madaline TF, Wassmer SC, et al. Fatal pediatric cerebral malaria is associated with intravascular monocytes and platelets that are increased with HIV coinfection. mBio. 2015;6:e01390-15.
48. Arnett HA, Mason J, Marino M, et al. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci. 2001;4:1116-1122.
49. Probert L. TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects. Neuroscience. 2015;302:2-22.
50. Feintuch CM, Saidi A, Seydel K, et al. Activated neutrophils are associated with pediatric cerebral malaria vasculopathy in Malawian children. mBio. 2015;7:e01300-15.